Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Raffles Medical GroupRAFLF 59 Earnings Yield (Joel Greenblatt) % is 0.00% as of Jun. 2026. GuruFocus rates RAFLF with a GF Score™ of 59/100 and a GF Value™ of $0.77 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 681 Healthcare Providers & Services companies, Raffles Medical Group ranks better than 69.31% on this metric.
Raffles Medical Group's Enterprise Value for the quarter that ended in Jun. 2026 was $1,206.8 Mil.
Raffles Medical Group's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was $71.3 Mil. Raffles Medical Group's Earnings Yield (Joel Greenblatt) for the quarter that ended in Jun. 2026 was 0.00%.
The historical rank and industry rank for Raffles Medical Group's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
RAFLF'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: 3.11 Med: 4.89 Max: 10.9
Current: 6.7
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of Raffles Medical Group was 10.90%. The lowest was 3.11%. And the median was 4.89%.
RAFLF's Earnings Yield (Joel Greenblatt) % is ranked better than 69.31% of 681
companies
in the Healthcare Providers & Services industry
Industry Median: 3.67
vs RAFLF: 6.70
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Raffles Medical Group's Forward Rate of Return (Yacktman) % for the quarter that ended in Jun. 2026 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Raffles Medical Group (OTCPK:RAFLF) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Raffles Medical Group Earnings Yield (Joel Greenblatt) % Related Terms
Raffles Medical Group Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Raffles Medical Group's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Raffles Medical Group Earnings Yield (Joel Greenblatt) % Chart
For the Medical Care Facilities subindustry, Raffles Medical Group's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Raffles Medical Group Earnings Yield (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Raffles Medical Group's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Raffles Medical Group's Earnings Yield (Joel Greenblatt) % falls into.
Raffles Medical Group Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Raffles Medical Groups Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2025 is calculated as
For company reported semi-annually or annually, GuruFocus only calculate annual data for Earnings Yield (Joel Greenblatt) and apply the annual figure to corresponding quarter.
What does a Earnings Yield (Joel Greenblatt) % of 0.00% mean?
Raffles Medical Group (RAFLF) has a Earnings Yield (Joel Greenblatt) % of 0.00% as of Jun. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Raffles Medical Group and its competitors. Over the past decade, Raffles Medical Group's Earnings Yield (Joel Greenblatt) % has ranged from 3.11 to 10.90. According to the industry distribution chart, Raffles Medical Group ranks #209 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 30.7%.
Is Raffles Medical Group's Earnings Yield (Joel Greenblatt) % too high?
Raffles Medical Group's current Earnings Yield (Joel Greenblatt) % is 0.00%. Over the past 10 years, this metric has ranged from a low of 3.11 to a high of 10.90. Based on the distribution chart, Raffles Medical Group ranks #209 out of 681 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Raffles Medical Group has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Raffles Medical Group's Earnings Yield (Joel Greenblatt) % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Raffles Medical Group ranks #209 out of 681 companies for Earnings Yield (Joel Greenblatt) %. This puts Raffles Medical Group in the upper half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 3.67. Historically, Raffles Medical Group's own Earnings Yield (Joel Greenblatt) % has ranged from 3.11 to 10.90 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median Earnings Yield (Joel Greenblatt) % among Healthcare Providers & Services companies is 3.67, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Raffles Medical Group and its competitors. For the Healthcare Providers & Services industry, the median Earnings Yield (Joel Greenblatt) % is 3.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Raffles Medical Group's current Earnings Yield (Joel Greenblatt) % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raffles Medical Group stock overvalued right now?
Based on GuruFocus' analysis, Raffles Medical Group (RAFLF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.77, compared to a current price of $0.67 — trading 13% below its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is 0.00%. Raffles Medical Group's overall GF Score™ is 59/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For Raffles Medical Group (RAFLF), the current Earnings Yield (Joel Greenblatt) % is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Raffles Medical Group (RAFLF) Overvalued in 2026?
Based on GuruFocus' analysis, Raffles Medical Group stock appears to be undervalued.
The current stock price of $0.67 is trading 13% below its estimated GF Value™ of $0.77.
GuruFocus considers Raffles Medical Group to be Modestly Undervalued.
Key valuation signals for RAFLF:
Earnings Yield (Joel Greenblatt) %: 0.00%
GF Value™: $0.77 vs. price of $0.67 (13% below fair value)
No single metric tells the full story. See the RAFLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Raffles Medical Group Ltd is an integrated private healthcare provider in Asia with operations in Singapore, China, Japan, Vietnam, and Cambodia. The company owns and operates a tertiary hospital, a network of medical and dental clinics, insurance services, Japanese and Traditional Chinese Medicine clinics, and a consumer healthcare division. The company's operating segment includes Healthcare services, Hospital Services, Investment Holdings, and Insurance Services. The company generates revenue from contracts with customers, Rental Income, and Insurance revenue. Geographically operates in Singapore, Greater China, Vietnam, Cambodia and Japan.
59GF Score
Get the complete analysis for RAFLF
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RAFLF has been successfully added to your 
